Pulmonary Disease Doctors in Tuscaloosa, AL Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Dr. Kyathanahally M. Dinesh Chandra, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255

Dr. Mohammad Azam, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255    Fax: 205-345-0813

Dr. Pedro Lopez, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255    Fax: 205-345-0813

Dr. Fausto Fabian Salinas, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255    Fax: 205-345-0813

Dr. Jeanne Poole Lipscomb, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1406 Mcfarland Blvd N, Suite 1c, Tuscaloosa, AL 35406 Phone: 205-343-0004    Fax: 205-343-0092

Ranju Chandrashekariah, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 711, Tuscaloosa, AL 35401 Phone: 205-345-2255    Fax: 205-345-0813

Narayan Krishnamurthy, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1406 Mcfarland Blvd N, Suite C, Tuscaloosa, AL 35406 Phone: 205-343-0004    Fax: 205-343-0092

News Archive

Positive results from Alkermes' ALKS 33 clinical trials announced

Alkermes, Inc. today announced positive topline data from two clinical trials of ALKS 33, an investigational oral opioid modulator for the treatment of addiction and other central nervous system disorders. Data from the studies, ALK33-003 and ALK33-004, showed that ALKS 33 was generally well tolerated and successfully blocked the effects of an opioid, with a duration of action that supports once daily dosing.

Implementation of value-driven outcomes tool in health care system can lead to lower costs, better quality

Implementing an analytic tool that allocates clinical care costs and quality measures to individual patient encounters was associated with significant improvements in value of care for 3 designated outcomes—total joint replacement, laboratory testing among medical inpatients, and sepsis management, according to a study appearing in the September 13 issue of JAMA.

Study provides detailed picture of genetics underlying type 2 diabetes

The largest study of its kind into type 2 diabetes has produced the most detailed picture to date of the genetics underlying the condition.

Locally advanced sinonasal malignancies: Proton beam radiation therapy promising

Proton beam radiation therapy shows encouraging results for patients with locally advanced sinonasal malignancies, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.

Read more Medical News

› Verified 5 days ago